Wednesday, March 18th, 2020 – In light of concerns surrounding COVID-19, the Department of Consumer Protection (DCP), Drug Control Division is issuing a reminder to prescribing practitioners regarding refills and reissuance of controlled substance prescriptions.
We want to be sure that practitioners know DCP is dedicated to ensuring that patients get the medication they need to stay healthy in a safe, secure manner.
Practitioners may issue prescription refills for controlled substances using their professional discretion for a patient under their care without seeing the patient in-person within certain parameters.
Today’s guidance includes information about:
- Drug schedule specific parameters for refills and reissuance
- Data entry requirements for the Prescription Drug Monitoring Program (PDMP)
- Electronic Prescribing of Controlled Substance (EPCS) requirements
- Basic information about EPCS waivers
Guidance released today can be found here.
More information about controlled substance prescriptions can be found in our guide: Prescribing Controlled Substances in the State of Connecticut.
If any practitioners have any questions regarding prescribing controlled substances, or are concerned with their ability to ensure ther patients have the medication they need, they are encouraged to contact us at dcp.drugcontrol@ct.gov.
###
Media Contact:
Lora Rae Anderson
lorarae.anderson@ct.gov
(860) 713-6019 (office)
(860) 247-8711 (cell)